T cell receptor alpha variable 26-1 (TRAV26-1)

T cell receptor alpha variable 26-1 (TRAV26-1) is a *protein-coding gene segment* that encodes the variable region of the alpha chain of the T cell receptor (TCR) complex. The TRAV26-1 gene contributes to the immense diversity of the TCR repertoire by recombining with various joining (J) segments during T cell development. TCRs are membrane proteins found on T lymphocytes and are fundamental in recognizing antigens presented by the major histocompatibility complex (MHC) on antigen-presenting cells. Upon antigen recognition, the TCR complex initiates multiple intracellular signaling pathways that drive T cell activation, proliferation, and differentiation. TRAV26-1 plays a role in generating antigen specificity of T cells, which is critical for adaptive immunity, immune surveillance, and host defense against pathogens and malignancies. It does not act as a receptor for any drug or ligand by itself but functions as a segment of the antigen-binding domain within the heterodimeric α:β TCR structure[1][2][4]. TRAV26-1 is one of the many variable (V) segments located within the complex *TCR alpha/delta locus* on the chromosome[2][4]. Each mature T cell expresses a single TCR composed of various alpha and beta gene segments, giving immense individual diversity within the immune system[2][4]. The biological importance of TRAV26-1 lies in its role in T cell antigen recognition and subsequent T cell-mediated immune responses[2][1]. It is not a stand-alone receptor; it is incorporated as part of a functional TCR heterodimer (with a beta chain), participating in immune specificity and signaling[1][2].

Other names

TRAV26-1TCRAV26S1TCRAV4S2TRAV261

General TCR-targeting drugs act by modulating TCR signaling, blocking T cell activation, or redirecting T cells (such as bispecific T cell engagers or engineered T cell therapies). No known mechanism of action is described for drugs selectively targeting TRAV26-1.